Antiangiogenic Effect of Graphene Oxide in Primary Human Endothelial Cells.

In this work, we exploited an integrated approach combining systematic analysis of cytotoxicity, angiogenic potential, and metabolomics to shed light on the effects of graphene oxide (GO) on primary human endothelial Huvec cells. Contrary to the outcomes observed in immortalized cell lines able to internalize a similar amount of GO, significant toxicity was found in Huvec cells at high GO concentrations (25 and 50 μg/mL). In particular, we found that the steric hindrance of GO intracellular aggregates perturbed the correct assembly of cytoskeleton and distribution of mitochondria. This was found to be primarily associated with oxidative stress and impairment of cell migration, affecting the formation of capillary-like structures. In addition, preliminary metabolomics characterization demonstrated that GO affects the consumption of niacinamide, a precursor of energy carriers, and several amino acids involved in the regulation of angiogenesis. Our findings suggest that GO acts at different cellular levels, both directly and indirectly. More precisely, the combination of the physical hindrance of internalized GO aggregates, induction of oxidative stress, and alteration of some metabolic pathways leads to a significant antiangiogenic effect in primary human endothelial cells.